These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

399 related items for PubMed ID: 6865850

  • 1. Oral contraceptives and the risk of cardiovascular disease.
    Med Lett Drugs Ther; 1983 Jul 22; 25(640):69-70. PubMed ID: 6865850
    [Abstract] [Full Text] [Related]

  • 2. The formulation of oral contraceptives: does the amount of estrogen make any clinical difference?
    Speroff L.
    Johns Hopkins Med J; 1982 May 22; 150(5):170-6. PubMed ID: 7043035
    [Abstract] [Full Text] [Related]

  • 3. Cardiovascular effects of oral contraceptives: a review.
    Stubblefield PG.
    Int J Fertil; 1989 May 22; 34 Suppl():40-9. PubMed ID: 2576258
    [Abstract] [Full Text] [Related]

  • 4. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
    Wahl P, Walden C, Knopp R, Hoover J, Wallace R, Heiss G, Rifkind B.
    N Engl J Med; 1983 Apr 14; 308(15):862-7. PubMed ID: 6572785
    [Abstract] [Full Text] [Related]

  • 5. Low-dose oral contraceptives: progestin potency, androgenicity, and atherogenic potential.
    Ellis J.
    Clin Ther; 1986 Apr 14; 8(6):607-18. PubMed ID: 3539347
    [Abstract] [Full Text] [Related]

  • 6. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V.
    Contracept Fertil Sex (Paris); 1985 Jan 14; 13(1 Suppl):425-30. PubMed ID: 12280210
    [Abstract] [Full Text] [Related]

  • 7. Progestin and estrogen potency of combination oral contraceptives and endometrial cancer risk.
    Maxwell GL, Schildkraut JM, Calingaert B, Risinger JI, Dainty L, Marchbanks PA, Berchuck A, Barrett JC, Rodriguez GC.
    Gynecol Oncol; 2006 Nov 14; 103(2):535-40. PubMed ID: 16740300
    [Abstract] [Full Text] [Related]

  • 8. Current perspectives on combination oral contraceptives.
    Smith MA, Youngkin EQ.
    Clin Pharm; 1984 Nov 14; 3(5):485-96. PubMed ID: 6386284
    [Abstract] [Full Text] [Related]

  • 9. [Cardiovascular risks of oral contraceptives: dose-response relationship].
    Kelleher CC.
    Contracept Fertil Sex (Paris); 1991 Apr 14; 19(4):285-8. PubMed ID: 12343220
    [Abstract] [Full Text] [Related]

  • 10. Oral contraceptives.
    Shearman RP.
    Aust Fam Physician; 1984 Sep 14; 13(9):685-91. PubMed ID: 6508652
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
    Scarabin PY, Plu-Bureau G, Zitoun D, Bara L, Guize L, Samama MM.
    Thromb Haemost; 1995 Sep 14; 74(3):928-32. PubMed ID: 8571323
    [Abstract] [Full Text] [Related]

  • 14. Arteriosclerosis risk. The roles of oral contraceptives and postmenopausal estrogens.
    Knopp RH.
    J Reprod Med; 1986 Sep 14; 31(9 Suppl):913-21. PubMed ID: 3772911
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. OC practice guidelines: minimizing side effects.
    Darney PD.
    Int J Fertil Womens Med; 1997 Sep 14; Suppl 1():158-69. PubMed ID: 9168375
    [Abstract] [Full Text] [Related]

  • 19. [How to choose an oral contraceptive in 1984].
    Rozenbaum H.
    Contracept Fertil Sex (Paris); 1984 Nov 14; 12(11):1201-6. PubMed ID: 12266609
    [Abstract] [Full Text] [Related]

  • 20. Oral contraceptives in 1984.
    Chapler EK.
    Iowa Med; 1984 Oct 14; 74(10):439-40, 442. PubMed ID: 6490338
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.